Integrated bioinformatics and experimental validation identify FOXQ1, GRIN2D, and SCNN1B as novel biomarkers for distinguishing high-risk sessile serrated lesions from hyperplastic polyps
Key Points
High-risk sessile serrated lesions can be distinguished from hyperplastic polyps using specific biomarkers.
Key findings identified three novel biomarkers: FOXQ1, GRIN2D, and SCNN1B, enhancing diagnosis.
Integrated bioinformatics and experimental validation methods were utilized in the biomarker identification process.
These findings may enable improved diagnosis strategies, potentially leading to better patient outcomes.
Integrated bioinformatics and experimental validation identify FOXQ1, GRIN2D, and SCNN1B as novel biomarkers for distinguishing high-risk sessile serrated lesions from hyperplastic polyps | Synapse